🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In this special issue, Thanzi joins research and policy partners to explore the challenges of allocating healthcare resources in LMIC settings, and presents new methods designed to bring research closer to policy to improve population health. Read more: valuehealthregionalissues.com/issue/S2212-10…

Applications now open for The Centre for Health Economics Visiting Fellowship. Our prestigious fellowship allows researchers to undertake a period of collaborative research at CHE, working with our team of leading health economists. More details at bit.ly/48PrmjO

🌟 Upcoming Event | Join our new session in #HTAsiaLink webinar series on "Methods for Estimating Health Opportunity Costs" 📆 Date: 27 February 2024 (Tue) 🕰 Time: 10:00-11:15 AM GMT / 17:00-18:15 PM ICT 🔗 Register now: us06web.zoom.us/webinar/regist…

Looking forward to Kuopio this summer for the Nordic Health Economists' Study Group! Abstract submission now open. I'll be talking about cost-effectiveness thresholds and pharmaceutical pricing.

We are very pleased that Rotterdam will be hosting the 31st European Workshop on Econometrics and Health Economics in September. Submit your papers before June: eur.nl/en/eshpm/event…

Really enjoyed reading this paper which makes enormous strides in reconciling CBA and CEA in health economics for public sector resource allocation: Social Decision-Making Analysis (SDMA). Bravo Francesco Longo et al! 🙌

Important stuff from Jessica Ochalek The Centre for Health Economics on the importance of estimating opportunity costs to inform a range of metrics of value and policy contexts - including optimal sharing of value! World Health Organization (WHO) #FairPricingForum

JOB OPPORTUNITY: Research Fellow in Health Economics, The University of Manchester, UK dlvr.it/T2WMH1

Our latest Research Summary by Karl Claxton 'How should we reward pharmaceutical innovation?' is published today. Read it at bit.ly/3PzAgKt

The latest in cost-effectiveness analyses... It will be a great discussion at this panel at the upcoming Boston symposium on Oct 26. Register: In person: tinyurl.com/5x3ey26t Virtual: tinyurl.com/yckdh8nr Anirban Basu Mel Whittington Society for Medical Decision Making (SMDM) The Centre for Health Economics

We're recruiting a 15 month post-doc research associate position to help us evaluate the health consequences among the elderly of the disability benefit reform in England from DLA to PIP. Economics at York Deadline 13th November. jobs.york.ac.uk/vacancy/resear…

Research associate position in the Department of Economics and Related Studies at the University of York, UK dlvr.it/TFRHXF #healtheconomics

When we approve expensive new pharmaceuticals, it's population health that pays the price. Time for reform? - find out more in this new article, co-authored by James Lomas 👉sciencedirect.com/science/articl…

It’s worth nothing in the end. But as far as respect-earning plays go, I could count on one hand the plays I’ve appreciated more from a Packers player. Undeniable heart from Josh Jacobs.

Doing the school run and trying to make a 9am meeting be like

Joint Asian and European Workshop on Econometrics and Health Economics – Singapore, August 27-30, 2025 dlvr.it/THMjhy #healtheconomics

Note earlier submission deadline! Easily one of the best conferences and the first joint venture for Asian and European groups?

Congratulations to Irene Papanicolas, Huseyin Naci, James Lomas, and Dan Ollendorf on being selected for the 2025 cohort of #NIHCM Research Grantees! Read more in the release: bit.ly/ResGr25 | #NIHCMGrants2025 James Lomas